1. Real-World Azacitidine use does not Replicate AZA-001 Results in Higher-Risk MDS/Low-Blast Count AML: Audit of 1101 Patients in Ontario, Canada. (April 2017) Authors: Mozessohn, L.; Cheung, M.; Fallahpour, S.; Gill, T.; Maloul, A.; Zhang, L.; Lau, O.; Buckstein, R. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Topic: AS02-Epidemiology: THE IMPACT OF GAINING OR LOSING TRANSFUSION INDEPENDENCE ON QUALITY OF LIFE IN MYELODYSPLASTIC SYNDROMES. (September 2021) Authors: Brailovski, E.; Mozessohn, L.; Abel, G.; Geddes, M.; Zhu, N.; Keating, M.-M.; Sabloff, M.; Christou, G.; Leber, B.; Khalaf, D.; Leitch, H.; Hilaire, E. St.; Finn, N.; Shamy, A.; Yee, K.; Storring, J.; Nevill, T.; Delage, R.; Elemary, M.; Banerji, V. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hepatitis B reactivation in HBsAg‐negative/HBcAb‐positive patients receiving rituximab for lymphoma: a meta‐analysis. Issue 10 (13th March 2015) Authors: Mozessohn, L.; Chan, K. K. W.; Feld, J. J.; Hicks, L. K. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 10(2015) Page Start: 842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: THE IMPACT OF CHIP ON CHEMOTHERAPY-RELATED OUTCOMES AND CLONAL DYNAMICS IN OLDER LYMPHOMA PATIENTS. (May 2023) Authors: Buckstein, R.; Cheung, M.; Mozessohn, L.; Chodirker, L.; Imrie, K.; Berinstein, N.; Chow, S.; Lopes, O.; Kupakuwana-Suk, G.; Fu, A.; Mcnaughton, A.; Parmentier, A.; Sasitharakumar, P.; Tsui, H.; Zhang, L.; Rauh, M. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS09-Quality of life-Disease experiences: LONGITUDINAL TRAJECTORY OF QUALITY OF LIFE IN MDS AND IMPACT OF PATIENT-RELATED FACTORS. (May 2023) Authors: Buckstein, R.; Chodirker, L.; Mozessohn, L.; Geddes, M.; Zhu, N.; Trottier, A.; Khalaf, D.; Leber, B.; St-Hilaire, E.; Finn, N.; Sabloff, M.; Christou, G.; Leitch, H.; Shamy, A.; Yee, K.; Storring, J.; Nevill, T.; Elemary, M.; Delage, R.; Houston, B. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS02-Epidemiology: EVALUATION OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE COHORT STUDY FROM THE CANADIAN MDS REGISTRY. (May 2023) Authors: Mathur, S.; Christou, G.; Delage, R.; Elemary, M.; Finn, N.; Geddes, M.; Houston, D.; Keating, M.-M.; Khalaf, D.; Leber, B.; Leitch, H.; Lother, S.; Mozessohn, L.; Nevill, T.; Parmentier, A.; Paulson, K.; Rimmer, E.; Sabloff, M.; Shamy, A.; St-Hilaire, E. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗